-
-
-
-
-
-
-
Provention Bio Inc. (PRVB) Confirms Posting of Briefing Documents for FDA Advisory Committee Meeting on Teplizumab
-
-
-
-
-
-
-
Provention Bio (PRVB) Completes Rolling Submission of BLA for Teplizumab for Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

